Xijing Hospital: Ischemia trials

The registry lists 10 Ischemia studies with Xijing Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3Phase 3 1Phase 4 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)Active, not recruitingNCT05512910Phase 4
• Predictive Study of Serum Endocan for Hemorrhagic Transformation After Reperfusion Therapies in Acute Ischemic StrokeStatus unknownNCT05228080
• Low-dose Aspirin Therapy in Patients With Ischemic Stroke and MicrobleedsStatus unknownNCT04504864Phase 4
• Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation PatientsStatus unknownNCT02644915Not applicable
• Mildronate for Acute Ischemic StrokeCompletedNCT01831011Phase 2
• Efficacy and Safety of Mildronate for Acute Ischemic StrokeStatus unknownNCT01800357Phase 2
• Study of Remote Ischemic PostconditioningCompletedNCT01450475Phase 1
• The Neuroprotection of Sevoflurane Preconditioning on Intracranial Aneurysm SurgeryStatus unknownNCT01204268Not applicable
• Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic StrokeCompletedNCT00815763Phase 3
• Ginsenoside-Rd for Acute Ischemic StrokeCompletedNCT00591084Phase 2